A Gram-negative, obligate anaerobic genus within the family veillonellaceae (class Negativicutes, phylum Firmicutes) defined by its specialized amino acid fermentation — the genus name literally means "acid from amino acids." Acidaminococcus ferments glutamate as its primary energy source, a metabolic strategy that links it to protein-rich diets and conditions characterized by altered amino acid metabolism. The genus has emerged as a consistently enriched taxon across breast cancer, schizophrenia, and type 2 diabetes, suggesting a pattern of pathobiont expansion in metabolic and inflammatory diseases.
Taxonomy
- Acidaminococcus fermentans — the type species; A. massiliensis is a more recently described species relevant to COVID-19 recovery studies.
- Family Veillonellaceae, order Veillonellales, class Negativicutes, phylum Firmicutes.
- Like other Negativicutes, Acidaminococcus is Gram-negative despite belonging to the predominantly Gram-positive Firmicutes.
Metal Dependencies
Iron:
- Iron-sulfur cluster proteins are essential for the glutamate fermentation pathway, particularly in the electron transfer steps of glutaconyl-CoA decarboxylase.
- Ferredoxin-dependent oxidoreductases support the anaerobic energy metabolism characteristic of amino acid-fermenting bacteria.
- Iron availability in inflammatory environments may favor Acidaminococcus expansion alongside other iron-dependent pathobionts.
Key Enzymes and Metabolic Features
- Glutamate dehydrogenase: Initiates glutamate catabolism, converting glutamate to 2-oxoglutarate. This enzyme's activity determines how effectively Acidaminococcus can exploit glutamate as an energy source.
- Glutaconyl-CoA decarboxylase: A biotin-dependent sodium pump that couples glutamate fermentation to ATP synthesis via a sodium gradient. This energy-conserving strategy is the metabolic hallmark of the genus and explains its specificity for glutamate-rich environments.
- Acetate and butyrate production: End products of glutamate fermentation include acetate and butyrate, though the overall metabolic impact may differ from fiber-derived SCFA production.
Ecological Role
In the Healthy Gut
Acidaminococcus is a minor member of the healthy gut microbiota, typically present at low abundance. Its niche — glutamate fermentation — is relatively specialized and does not compete directly with the dominant fiber-fermenting bacteria.
In Dysbiosis
Acidaminococcus expands in conditions characterized by:
- Increased luminal amino acid availability (protein maldigestion, mucosal damage releasing tissue-derived amino acids)
- Reduced competition from fiber fermenters (low-fiber Western diets eliminate the dominant SCFA-producing competitors)
- Inflammatory environments where iron release from damaged tissue supports iron-dependent metabolism
Conditions Associated
Breast Cancer
Acidaminococcus is enriched in breast cancer patients (24% prevalence vs. 9% in controls), alongside hungatella and tyzzerella. Notably, Acidaminococcus-positive participants had significantly lower whole fruit intake (HEI-2015 scores, p = 0.005) altinok dindar 2023 gut microbiota breast cancer diet, connecting dietary patterns to pathobiont expansion.
Schizophrenia
Consistently up-regulated in schizophrenia across multiple studies in a systematic vote-counting meta-analysis, alongside prevotella, Succinivibrio, and other taxa li 2024 alterations gut microbiota schizophrenia vote counting.
Type 2 Diabetes
Identified as a key disease-discriminating taxon (absolute R-value > 0.6) in a multi-omics study of the gut microbiome-metabolome axis in T2D patients al bataineh 2023 multi omics microbiome metabolome t2d fiber.
COVID-19 Recovery
Acidaminococcus massiliensis was a key predictive feature in a random forest model distinguishing COVID-19 recovery status (AUC 0.99). Dynamic cycling was observed: enriched at baseline and 6 months but absent at 3 months, suggesting fluctuating dominance during immune reconstitution li 2025 long term gut microbiota alterations covid recovery.
Key Studies
- altinok dindar 2023 gut microbiota breast cancer diet (case-control, n=50) — Identified Acidaminococcus enrichment in breast cancer with dietary correlation.
- li 2024 alterations gut microbiota schizophrenia vote counting (systematic review/meta-analysis) — Consistently up-regulated in schizophrenia across studies.
- li 2025 long term gut microbiota alterations covid recovery (prospective cohort) — A. massiliensis as predictive feature in COVID-19 recovery.
- al bataineh 2023 multi omics microbiome metabolome t2d fiber (cross-sectional) — Disease-discriminating taxon in T2D.
Cross-References
- veillonellaceae — parent family; shared Negativicutes classification
- breast cancer — enriched alongside Hungatella and Tyzzerella
- schizophrenia — consistently up-regulated across studies
- type 2 diabetes — disease-discriminating taxon
- hungatella — co-enriched in breast cancer
- tyzzerella — co-enriched in breast cancer
- iron — iron-dependent amino acid fermentation pathway